While direct evidence of DN T cells in canine tumors is limited, their immunoregulatory properties in tissues (97, 98) and the clinical activity of CTLA4-targeted therapies in dogs (54) support a potential functional role within the tumor microenvironment. This evidence concerns the gene CTLA4 and neoplasm.